We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Celularity

News List

Celularity and GX Acquisition announce merger agreement to create publicly listed leader in allogeneic cellular therapy pharmaceutical-business-review
January 12, 2021
Celularity and GX Acquisition Corp. announced they have entered into a definitive merger agreement pursuant to which GX Acquisition Corp. will combine with Celularity.
Celularity Doses First Patient in Trial Evaluating CYNK-001 in COVID-19 Patients americanpharmaceuticalreview
September 24, 2020
Celularity announced the first patient was dosed in a Phase I/II study of human placental hematopoietic stem cell derived NK cells (CYNK-001) for the treatment of adults with COVID-19 as part of a national clinical trial.
Cryoport, Celularity Enter Supply Chain Partnership contractpharma
April 15, 2019
Celularity to use Cryoport’s temperature controlled logistics solutions...